Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Oruka Therapeutics, Inc. (ORKA) had Free Cash Flow per Share of $-3.46 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-83.72M |
|
-- |
|
-- |
|
$88.12M |
|
$-88.12M |
|
$4.40M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-88.12M |
|
$-90.34M |
|
16.79M |
|
16.79M |
|
$-3.87 |
|
$-3.87 |
|
| Balance Sheet Financials | |
$376.87M |
|
$0.16M |
|
$19.15M |
|
$396.02M |
|
$13.04M |
|
-- |
|
$0.76M |
|
$13.80M |
|
$379.29M |
|
$382.22M |
|
$382.22M |
|
37.44M |
|
| Cash Flow Statement Financials | |
$-57.84M |
|
$-330.13M |
|
$449.54M |
|
-- |
|
$61.58M |
|
$61.58M |
|
$14.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-58.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.07% |
|
-21.90% |
|
-21.14% |
|
-21.90% |
|
$10.21 |
|
|
Free Cash Flow per Share |
$-3.46 |
$-3.44 |
|